Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for health advice, go to the NHS website. And if you are looking for the latest travel information, and advice about the government response to the outbreak, go to the GOV.UK website.
A stage two resource alert has been issued to support providers of NHS-funded care to minimise the risk of distress and death caused by inappropriate doses of naloxone.
The alert highlights a number of resources now available to help providers ensure their local protocols and training related to naloxone reflect best practice. These resources have been developed in response to a previous alert issued in November 2014 to raise awareness of the risk.
Whilst naloxone use can be life-saving in respiratory depression and respiratory arrest, inappropriate doses of naloxone can cause a rapid reversal of the physiological effects of long-term opioids or opiates used for pain control, leading to intense pain and distress, and acute withdrawal syndrome. This can lead to hypertension, cardiac arrhythmias, pulmonary oedema and cardiac arrest.